NEW YORK, Dec 21 - Aurora Biosciences said Thursday that Bristol-Myers Squibb’s Pharmaceutical Research Institute has validated Aurora’s ultra-high throughput screening system, the UHTSS Platform.

This is the first time one of Aurora’s development partners has validated a complete UHTSS Platform, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.